SNGX
Soligenix, Inc.
There isn't enough reported data to score SNGX yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SNGX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
SNGX's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SNGX PE Valuation
SNGX has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SNGX Forward outlook
There aren't enough analyst estimates for SNGX to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SNGX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$31.84 | +$52.16 |
| Q2 2023 | -$48.48 | +$37.92 |
| Q1 2023 | -$58.72 | +$25.28 |
| Q4 2022 | -$76.96 | -$2.56 |
| Q3 2022 | -$84.00 | +$2.40 |
| Q2 2022 | -$86.40 | -$7.20 |
| Q1 2022 | -$84.00 | +$7.20 |
| Q4 2021 | -$74.40 | +$79.20 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 116% for SNGX versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
SNGX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2024 | $2.3K | -99% |
| Q1 2024 | $117K | -54% |
| Q4 2023 | $244.8K | -33% |
| Q3 2023 | $130.4K | -21% |
| Q2 2023 | $206.9K | -9.5% |
| Q1 2023 | $257.2K | +37% |
| Q4 2022 | $366.1K | +33% |
| Q3 2022 | $166.1K | -11% |
UNH has the stronger quarterly revenue trend. Revenue is down 100% for SNGX versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2024 | -74495% | -73707 points |
| Q1 2024 | -1809% | -973 points |
| Q4 2023 | -873% | +102 points |
| Q3 2023 | -1364% | +491 points |
| Q2 2023 | -788% | +697 points |
| Q1 2023 | -836% | +1398 points |
| Q4 2022 | -975% | +665 points |
| Q3 2022 | -1855% | -42 points |
SNGX's operating margin was −74495% last quarter, down 73707 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
SNGX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$2.4M | -$510.7K |
| Q4 2025 | -$2.7M | -$514.2K |
| Q3 2025 | -$2.9M | -$22.8K |
| Q1 2025 | -$1.8M | -$504.5K |
| Q4 2024 | -$2.2M | -$404.6K |
| Q3 2024 | -$2.9M | -$224.1K |
| Q2 2024 | -$1.9M | +$5.5K |
| Q1 2024 | -$1.3M | +$823.8K |
SNGX has the stronger cash trend. Its trailing FCF is up 6.1% versus its history, compared with UNH at up 5.2%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
SNGX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +39% | +6.2M shares |
| 1 year | +576% | +18.9M shares |
| 3 years | +12241% | +22M shares |
| 5 years | +17874% | +22M shares |
SNGX has 22M diluted shares, up 576% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over SNGX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
SNGX Net Leverage
SNGX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SNGX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.3 | Neutral |
| Stochastic | 17.2 | Oversold |
SNGX's weekly RSI is 35 (neutral) and its Stochastic is 17 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SNGX PE vs Healthcare Sector
SNGX has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SNGX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.36 | 11% below |
| 20 week MA | $0.37 | 14% below |
| 50 week MA | $0.77 | 58% below |
| 100 week MA | $1.44 | 78% below |
| 200 week MA | $8.25 | 96% below |
SNGX is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over SNGX on trend strength, trading above more of its moving averages.
SNGX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $340.8 | $321.6 | -5.6% |
| 2021 | $321.6 | $184.3 | -43% |
| 2022 | $184.3 | $154.9 | -16% |
| 2023 | $154.9 | $12.1 | -92% |
| 2024 | $12.1 | $2.89 | -76% |
| 2025 | $2.89 | $1.37 | -53% |
| 2026 YTD | $1.37 | $0.32 | -77% |
SNGX has finished every year since 2020 lower, and it's down 77% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over SNGX on returns for 2026, with the stronger performance.